Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Pliant Therapeutics Inc (NASDAQ: PLRX) closed at $1.54 in the last session, up 2.67% from day before closing price of $1.50. In other words, the price has increased by $2.67 from its previous closing price. On the day, 0.81 million shares were traded.
Ratios:
We take a closer look at PLRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.91 and its Current Ratio is at 10.91. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 17 ’25 when Coulie Bernard sold 52,419 shares for $11.20 per share. The transaction valued at 587,150 led to the insider holds 430,517 shares of the business.
Cummings Keith Lamont sold 20,148 shares of PLRX for $225,680 on Jan 17 ’25. The Chief Financial Officer now owns 262,608 shares after completing the transaction at $11.20 per share. On Jan 17 ’25, another insider, Hull Hans, who serves as the Chief Business Officer of the company, sold 15,936 shares for $11.20 each. As a result, the insider received 178,501 and left with 211,558 shares of the company.
Stock Price History:
Over the past 52 weeks, PLRX has reached a high of $16.52, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is -18.05%, while the 200-Day Moving Average is calculated to be -84.74%.
Shares Statistics:
A total of 60.86M shares are outstanding, with a floating share count of 53.12M. Insiders hold about 13.46% of the company’s shares, while institutions hold 99.75% stake in the company.
